Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of GenVivo, to accelerate the achievement of major clinical…
Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH)Findings suggest BIOX-101…
September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK…
NOTTINGHAM, United Kingdom, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope®…
TORRINGTON, CT , Sept. 10, 2025 (GLOBE NEWSWIRE) -- In response to the growing demands for senior living apartments, Keystone…
Calgary, Alberta--(Newsfile Corp. - September 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Company"), the leading autologous…
Children using Luminopia now have access to hundreds of episodes from the original Pokémon animated series, making amblyopia treatment even…
From gene editing breakthroughs to AI-driven drug discovery to epigenetic interventions, this year's Summit explores the radical advances reshaping how…
Close to $600,000 in Funding Provided to 14 Academic Researchers from Across the US to Advance New Innovations to Predict,…
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling…